-
公开(公告)号:US10138300B2
公开(公告)日:2018-11-27
申请号:US15640935
申请日:2017-07-03
Applicant: DEVELOPMENT CENTER FOR BIOTECHNOLOGY
Inventor: Jiann-Shiun Lai , Li-Shuang Ai , Yan-Da Lai , Yen-Yu Wu , Yi-San Tsai , Yi-Jiue Tsai , Juo-Yu Huang , Cheng-Chou Yu , Chuan-Lung Hsu , Chien-Tsun Kuan , Szu-Liang Lai , Li-Ya Wang
IPC: C07K16/28 , C07K16/30 , G01N33/74 , A61K51/10 , A61K31/4439 , C07K14/71 , C07K16/00 , A61K47/68 , A61K47/48 , A61K39/00
Abstract: The present invention relates to an antibody or antigen-binding fragment thereof that bind human vascular endothelial growth factor receptor 2 (VEGFR-2). The present invention also relates to a method for inhibiting VEGFR-2-mediated signaling in a subject in need, a method for treating diseases and/or disorders caused by or related to VEGFR-2 activity and/or signaling in a subject afflicted with the diseases and disorders, a method for treating tumor in a subject afflicted with the tumor, a method for inhibiting cell proliferation of endothelial cells in a subject in need, and a method for detecting human vascular endothelial growth factor receptor in a sample.
-
公开(公告)号:US10752688B2
公开(公告)日:2020-08-25
申请号:US15859506
申请日:2017-12-30
Applicant: Development Center for Biotechnology
Inventor: Yu-Chen Yang , Li-Yu Chen , Chia-Hua Li , Pei-Han Tai , Hong-Kai Chen , Ying-Yung Lok , Chih-Yung Hu , Chien-Tsun Kuan , Chung-Hsiun Wu
IPC: C07K16/00 , C07K16/28 , A61P35/00 , G01N33/574 , A61K39/00
Abstract: An anti-human T-cell immunoglobulin domain and mucin domain 3 (TIM-3) antibody, can bind the peptides, comprising the amino-acid sequence RKGDVSL (SEQ ID NO: 9) and/or EKFNLKL (SEQ ID NO: 10) of human TIM-3 protein. The antibody can regulate immune cell activity. The antibody or binding fragment thereof is useful in diagnosis, prognosis, and treatment of cancers that have been reported to express cell-surface TIM-3 such as lung, liver, esophageal cancer and solid tumors.
-
公开(公告)号:US20180186884A1
公开(公告)日:2018-07-05
申请号:US15640935
申请日:2017-07-03
Applicant: DEVELOPMENT CENTER FOR BIOTECHNOLOGY
Inventor: JIANN-SHIUN LAI , Li-Shuang Ai , Yan-Da Lai , Yen-Yu Wu , Yi-San Tsai , Yi-Jiue Tsai , Juo-Yu Huang , Cheng-Chou Yu , Chuan-Lung Hsu , Chien-Tsun Kuan , Szu-Liang Lai , Li-Ya Wang
IPC: C07K16/28 , G01N33/74 , C07K16/30 , A61K51/10 , A61K31/4439
CPC classification number: C07K16/2863 , A61K31/4439 , A61K47/6803 , A61K47/6849 , A61K51/1027 , A61K51/1096 , A61K2039/505 , A61K2039/507 , C07K14/71 , C07K16/005 , C07K16/2818 , C07K16/30 , C07K2317/24 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/622 , C07K2317/76 , C07K2317/77 , C07K2317/92 , G01N33/74 , G01N2333/71
Abstract: The present invention relates to an antibody or antigen-binding fragment thereof that bind human vascular endothelial growth factor receptor 2 (VEGFR-2). The present invention also relates to a method for inhibiting VEGFR-2-mediated signaling in a subject in need, a method for treating diseases and/or disorders caused by or related to VEGFR-2 activity and/or signaling in a subject afflicted with the diseases and disorders, a method for treating tumor in a subject afflicted with the tumor, a method for inhibiting cell proliferation of endothelial cells in a subject in need, and a method for detecting human vascular endothelial growth factor receptor in a sample.
-
-